C07D 491/00
Heterocyclic compounds containing in the condensed ring system both one or more
Official title: Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
C07D491/00 (Heterocyclic compounds containing in the condensed ring system both one or more) appears on 9,305 US grants and 10,695 published applications in this corpus.
Search patents in C07D- Granted patents
- 9,305
- Published applications
- 10,695
- Assignees
- 3,106
- Inventors
- 26,372
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 60 | 0 |
| 1977 | 62 | 0 |
| 1978 | 57 | 0 |
| 1979 | 50 | 0 |
| 1980 | 53 | 0 |
| 1981 | 78 | 0 |
| 1982 | 50 | 0 |
| 1983 | 69 | 0 |
| 1984 | 65 | 0 |
| 1985 | 66 | 0 |
| 1986 | 83 | 0 |
| 1987 | 82 | 0 |
| 1988 | 75 | 0 |
| 1989 | 83 | 0 |
| 1990 | 62 | 0 |
| 1991 | 79 | 0 |
| 1992 | 89 | 0 |
| 1993 | 77 | 0 |
| 1994 | 71 | 0 |
| 1995 | 96 | 0 |
| 1996 | 120 | 0 |
| 1997 | 151 | 0 |
| 1998 | 126 | 0 |
| 1999 | 129 | 0 |
| 2000 | 140 | 0 |
| 2001 | 163 | 42 |
| 2002 | 185 | 155 |
| 2003 | 173 | 286 |
| 2004 | 171 | 348 |
| 2005 | 135 | 301 |
| 2006 | 214 | 325 |
| 2007 | 164 | 328 |
| 2008 | 173 | 300 |
| 2009 | 210 | 351 |
| 2010 | 238 | 400 |
| 2011 | 240 | 395 |
| 2012 | 265 | 373 |
| 2013 | 359 | 424 |
| 2014 | 358 | 472 |
| 2015 | 380 | 462 |
| 2016 | 345 | 516 |
| 2017 | 414 | 439 |
| 2018 | 359 | 466 |
| 2019 | 413 | 472 |
| 2020 | 351 | 560 |
| 2021 | 347 | 463 |
| 2022 | 340 | 520 |
| 2023 | 306 | 667 |
| 2024 | 342 | 630 |
| 2025 | 365 | 569 |
| 2026 | 222 | 431 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Organic compound, light-emitting device, light-emitting apparatus, electronic appliance, and lighting device6 Oct 2026US 12,753,182 B2Semiconductor Energy Laboratory Co.Ltd.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystalline forms of a parp1 inhibitor8 Oct 2026US 2026/0308163 A1Gilead Sciences, Inc.
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Brm selective degradation agent and use thereof8 Oct 2026US 2026/0308165 A1
- Oxadiazolyl dihydropyrano[2,3-b]pyridine inhibitors of hipk2 for treating kidney fibrosis8 Oct 2026US 2026/0308166 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Methods for repairing damaged intervertebral discs571US 6,602,248 B1Arthro Care Corporation · 2003
- Methods for repairing damaged intervertebral discs418US 7,318,823 B2ArthroCare Corporation · 2008
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Apoptosis promoters226US 7,390,799 B2Abbott Laboratories · 2008
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997